Summary
Boston Scientific Corporation (BSX) announced on May 18, 2026, that it has entered into an Accelerated Share Repurchase (ASR) agreement for $2 billion. This ASR is part of the company's previously authorized $5 billion share repurchase program, leaving $3 billion remaining under this authorization upon completion of the ASR. The ASR involves an initial repurchase of approximately 30.4 million shares, valued at 80% of the repurchase price based on the May 15, 2026 closing price. The final number of shares repurchased will be determined by the volume-weighted average price during the ASR term, subject to discounts and adjustments. The ASR is expected to conclude by June 30, 2026, and is intended to enhance shareholder value by reducing the number of outstanding shares.
Key Highlights
- 1Boston Scientific has initiated a $2 billion Accelerated Share Repurchase (ASR) program.
- 2The ASR is part of a larger, previously announced $5 billion share repurchase authorization.
- 3Upon completion of this ASR, $3 billion will remain available under the existing repurchase authorization.
- 4The ASR will initially result in the repurchase of approximately 30.4 million shares.
- 5The final number of shares repurchased will be based on the volume-weighted average price during the ASR term.
- 6The ASR agreement is with JPMorgan Chase Bank, National Association.
- 7The ASR is expected to be completed by June 30, 2026.